Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -100.00% vs 60.00% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 13.48% vs 3,401.64% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is -39.86% vs 5,720.00% in Mar 2025
Compare Balance Sheet Results of Bacil Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.97
7.87
6.10
77.51%
Share Warrants & Outstandings
Total Reserve
10.84
9.73
1.11
11.41%
Shareholder's Funds
24.81
17.60
7.21
40.97%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
2.47
-2.47
-100.00%
Secured Loans
0.00
1.00
-1.00
-100.00%
Unsecured Loans
0.00
1.47
-1.47
-100.00%
Deferred Tax Assets / Liabilities
-0.62
0.79
-1.41
-178.48%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.68
-0.68
-100.00%
Total Non-Current Liabilities
-0.62
3.94
-4.56
-115.74%
Current Liabilities
Trade Payables
0.02
12.54
-12.52
-99.84%
Other Current Liabilities
0.18
7.60
-7.42
-97.63%
Short Term Borrowings
0.00
28.55
-28.55
-100.00%
Short Term Provisions
2.38
1.74
0.64
36.78%
Total Current Liabilities
2.58
50.43
-47.85
-94.88%
Total Liabilities
26.77
71.96
-45.19
-62.80%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
18.86
-18.86
-100.00%
Less: Accumulated Depreciation
0.00
10.45
-10.45
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
8.41
-8.41
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
24.24
0.01
24.23
242,300.00%
Long Term Loans & Advances
0.78
0.07
0.71
1,014.29%
Other Non Current Assets
0.00
0.28
-0.28
-100.00%
Total Non-Current Assets
25.02
8.77
16.25
185.29%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
30.84
-30.84
-100.00%
Sundry Debtors
1.18
21.92
-20.74
-94.62%
Cash and Bank
0.57
1.54
-0.97
-62.99%
Other Current Assets
0.00
0.57
-0.57
-100.00%
Short Term Loans and Advances
0.00
8.32
-8.32
-100.00%
Total Current Assets
1.75
63.19
-61.44
-97.23%
Net Current Assets (Including Current Investments)
-0.83
12.76
-13.59
-106.50%
Total Current Assets Excluding Current Investments
1.75
63.19
-61.44
-97.23%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
26.77
71.96
-45.19
-62.80%
Contingent Liabilities
0.00
0.17
-0.17
-100.00%
Total Debt
0.00
31.03
-31.03
-100.00%
Book Value per share (adjusted)
17.76
22.37
-4.61
-20.61%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs 60.00% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Annual - Investments
Investments 24.24 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.48% vs 3,401.64% in Mar 2025
Annual - Current Assets
Current Assets 1.75 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -39.86% vs 5,720.00% in Mar 2025
Footer loading
